Dr Nicole Moore
Position | Strategic Development Manager |
---|---|
Org Unit | Research Services |
nicole.moore@adelaide.edu.au | |
Telephone | +61 8 8313 6523 |
Location |
Floor/Room
Level Three
,
44-60 Rundle Mall - Rundle Mall Plaza
,
North Terrace
|
-
Publications
Journal Articles
1. McNamara, K.M.; Moore, N.L.; Hickey, T.E.; Sasano, H.; Tilley, W.D.
Complexities of androgen receptor signalling in breast cancer. Endocrine-Related Cancer, 2014; 21(4):T161-T1812. Moore, N.L.; Edwards, D.P.; Weigel, N.L.
Cyclin A2 and its associated kinase activity are required for optimal induction of progesterone receptor target genes in breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology, 2014; 144:471-4823. Ochnik, A.M.; Moore, N.L.; Jankovic-Karasoulos, T.; Bianco-Miotto, T.; Ryan, N.K.; Thomas, M.R.; Birrell, S.N.; Butler, L.M.; Tilley, W.D.; Hickey, T.E.
Antiandrogenic actions of medroxyprogesterone acetate on epithelial cells within normal human breast tissues cultured ex vivo. Menopause, 2014; 21(1):79-884. Moore, N.; Buchanan, G.; Harris, J.; Selth, L.; Bianco-Miotto, T.; Hanson, A.; Birrell, S.; Butler, L.; Hickey, T.; Tilley, W.
An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity. Endocrine-Related Cancer, 2012; 19(4):599-6135. Moore, N.; Hickey, T.; Butler, L.; Tilley, W.
Multiple nuclear receptor signaling pathways mediate the actions of synthetic progestins in target cells. Molecular and Cellular Endocrinology, 2012; 357(1-2):60-706. Moore, N.L.; Weigel, N.L.
Regulation of progesterone receptor activity by cyclin dependent kinases 1 and 2 occurs in part by phosphorylation of the SRC-1 carboxyl-terminus. The International Journal of Biochemistry & Cell Biology, 2011; 43(8):1157-11677. Need, E.; Scher, H.; Peters, A.; Moore, N.; Cheong, A.; Ryan, C.; Wittert, G.; Marshall, V.; Tilley, W.; Buchanan, G.
A Novel Androgen Receptor Amino Terminal Region Reveals Two Classes of Amino/Carboxyl Interaction-Deficient Variants with Divergent Capacity to Activate Responsive Sites in Chromatin. Endocrinology, 2009; 150(6):2674-26828. Peters, A.; Buchanan, G.; Ricciardelli, C.; Bianco-Miotto, T.; Centenera, M.; Harris, J.; Jindal, S.; Segara, D.; Jia, L.; Moore, N.; Henshall, S.; Birrell, S.; Coetzee, G.; Sutherland, R.; Butler, L.; Tilley, W.
Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer. Cancer Research, 2009; 69(15):6131-61409. Cops, E.; Bianco-Miotto, T.; Moore, N.; Clarke, C.; Birrell, S.; Butler, L.; Tilley, W.
Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors. Journal of Steroid Biochemistry and Molecular Biology, 2008; 110(3-5):236-24310. Moore, N.; Narayanan, R.; Weigel, N.
Cyclin dependent kinase 2 and the regulation of human progesterone receptor activity. Steroids, 2007; 72(2):202-20911. Weigel, N.; Moore, N.
Cyclins, cyclin dependent kinases, and regulation of steroid receptor action. Molecular and Cellular Endocrinology, 2007; 265¿266:157-16112. Weigel, N.; Moore, N.
Kinases and protein phosphorylation as regulators of steroid hormone action. Nuclear Receptor Signaling, 2007; 5:1-1313. Weigel, N.; Moore, N.
Steroid receptor phosphorylation: a key modulator of multiple receptor functions. Molecular Endocrinology, 2007; 21(10):2311-231914. Srinivas, H.; Xia, D.; Moore, N.; Uray, I.; Kim, H.; Ma, L.; Weigel, N.; Brown, P.; Kurie, J.
Akt phosphorylates and suppresses the transactivationof retinoic acid receptor alpha. Biochemical Journal, 2006; 395(3):653-66215. Buchanan, G.; Birrell, S.; Peters, A.; Bianco-Miotto, T.; Ramsay, K.; Cops, E.; Yang, M.; Harris, J.; Simila, H.; Moore, N.; Bentel, J.; Ricciardelli, C.; Horsfall, D.; Butler, L.; Tilley, W.
Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate. Cancer Research, 2005; 65(18):8487-849616. Buchanan, G.; Yang, M.; Cheong, A.; Harris, J.; Irvine, R.; Lambert, P.; Moore, N.; Raynor, M.; Neufing, P.; Coetzee, G.; Tilley, W.
Structural and functional consequences of glutamine tract variation in the androgen receptor. Human Molecular Genetics, 2004; 13(16):1677-169217. Buchanan, G.; Yang, M.; Harris, J.; Nahm, H.; Han, G.; Moore, N.; Bentel, J.; Matusik, R.; Horsfall, D.; Marshall, V.; Greenberg, N.; Tilley, W.
Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function. Molecular Endocrinology, 2001; 15(1):45-56Book Chapters
1. Moore, N.L.; Centenera, M.M.; Butler, L.M.; Hickey, T.E. and Tilley, W.D.
Androgen and the Androgen Receptor, in: Gelmann E, Sawyers C and Rauscher F III (Eds.), Molecular Oncology: Causes of Cancer and Targets for Treatment, Chapter 32:378-391 (2014). Cambridge University Press, New York.
The information in this directory is provided to support the academic, administrative and business activities of the University of Adelaide. To facilitate these activities, entries in the University Phone Directory are not limited to University employees. The use of information provided here for any other purpose, including the sending of unsolicited commercial material via email or any other electronic format, is strictly prohibited. The University reserves the right to recover all costs incurred in the event of breach of this policy.
Entry last updated: Friday, 23 Feb 2024
To link to this page, please use the following URL: https://www.adelaide.edu.au/directory/nicole.moore